Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01889 (
ankylosing spondylitis
)
5,717
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The lymphocyte response of mononuclear cells (MNC) to Klebsiella (Klebs) was studied in
ankylosing spondylitis
(
ASP
) and, for comparison, in patients convalescing from Klebs infection and in HLA-B27+ and B27- healthy blood donors. When large doses of various Klebs cell envelope structures were used, MNC from all healthy blood donors were stimulated to produce
LIF
but not to synthesize significant amounts of DNA. In contrast, MNC from convalescent patients showed
LIF
synthesis (but no significant proliferation) even when small doses of the Klebs biostructures were used. This heightened
LIF
response to Klebs was long-standing and could be demonstrated even after serum antibodies had vanished. Very similarly, MNC from
ASP
patients did not proliferate significantly, but could be activated to produce
LIF
even with small doses of Klebs. The heightened
LIF
response to Klebs in
ASP
appeared to be correlated with the clinical activity and/or duration of the disease. In contrast, there was no correlation between the presence of HLA-B27 in
ASP
patients or healthy controls and the
LIF
or proliferative response to Klebs.
...
PMID:Lymphocyte response to Klebsiella in ankylosing spondylitis. 310 Feb 99